You are on page 1of 45

15.03.

2012

222012 ,


.1 ' -
.2 ' - 3 - -
.3 ' - 7 -

.4 ' 9 ,2 19 -
.5 ' -


.6 ' - 13 -
.7 ' - 12 -
.8 ' - (17) -

.9 ' - (17) -

' -
-II

...

/ ,
( " ")
(' .)1.2
o

' -
8:

,
" ,
-
,PCT Rule 13:


)(a priori


/ )(a posteriori

' -

,
,
.

8 ,
12 ,5 ,413 -
( .' .)6.2

' -

.( 78 . 2 - ):
o

-
.

-

(' .)8" :
"...

' -

:
o

,
,proviso .

, .
o


. ,

)(out of ambit

(' (13) ,' 12).

' -


(20)(... :)3
prodrug, substantially, approximately, about

(' )13.3

' -

100 - ,

.( 78 .

)
-
(' .)13
" - ...
...:
100".

' -

" ... " .


... (' [ .)14
(17)]

:
.[ 63 .].

:
"
,
, " (' .)21.3

' -
3 - Incorporation by reference (' :)17
.1 ... ...

.2 ...

.3 ...
...
,
.

' -


.
.

,
,
/ .


,
(' .)22

' -

:proviso ,
o

... .

4.
o

...
5.

(' )22

' -

" ,
.

,
..."
(' )27
o

[ (' ,3
)...7 ((17)/.])70.

' -
-V

,15/07/2010 :

...

,15/07/2010 .
o

.?81 .

' -
(' )3

.
o


. - 1 )P(23
) (disclaimer

13.

' -
(' )3

:
.

:
.

' -

(' )3
o


, ,
!

' -
-VII
" ' ,SMITH-KLINE
:
o


. ...

, "

" [ ]

' -
o

... 5

[ ]

...
,
2 9

' -
"
" " - ,
".

' -
-VIII

[ ,
.]45


(' )5.3

, ... ...
. ...:27 .
... (' )6.2

' -
-VIII


. ,27 .

(' )6.3

' -
-IX

:...
o

...

,
o


...
. ...13 .

' -
-X

"
, .:



" : "

...

- 7
- 7

,
,

)1(7 .
(' ,3.1
,II )

[ , use
, ,
.( 30 .' ,4 ,II )]

- 7

, ,
( ) .
...

( )technical feature .

' , 9 ,219 -
' , 9 ,2 -19 -:

...
/

... ... ...

2 9
.
19

.

' , 9 ,219 -

... 2 ...
,

.

... ...

... [] (39).

... 19 ... [...]


.

' , 9 ,219 -
:
.1
.

.2 ' '
, '
' [" The
]Welcome Foundation

' , 9 ,219 -
.3 ...
/
.... ...

...
. .
.4
.

. .

' , 9 ,219 -
.3 /
(" VIII
")

'' " "


.
o

:
- .

" - 13
" - 13
3 :
(10) (

) ," ,1996-
(20)( )3 .
20
-
.PCT

" - 13
" - 13

""
, ,

,
.
(' .)6

" - 13

,
(13) .

.

.
(' )7


, -III
" - (17)

(17)

, / /

[ / ]
(17).
-

[ (17) ,
:
.1 ,


.2 ,
]

[ " " ]PCT

(17) ,

(17) .


.
.



(17) .( 70 .):

.1
...
.
,
' ,


.2 ...

...

.

(17)


4/ 5

(' 5.5.2

-VIII ).

" - (17)

" - (17) -
, .
, ,
.

You might also like